The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents vs bare-metal stents during percutaneous coronary intervention

被引：0
|
作者：
Kalapatapu, Kumar [1 ]
Dilmanian, Hajir [1 ]
Aronow, Wilbert S. [1 ]
Mundia, Mubasir [1 ]
Pucillo, Anthony L. [1 ]
Weiss, Melvin B. [1 ]
Monsen, Craig E. [1 ]
机构：
[1] New York Med Coll, Valhalla, NY 10595 USA
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：545S / 545S
页数：1
相关论文
共 50 条
  • [21] Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis
    Almalla, Mohammad
    Pross, Verena
    Marx, Nikolaus
    Hoffmann, Rainer
    CORONARY ARTERY DISEASE, 2012, 23 (07) : 492 - 496
  • [22] Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
    Kereiakes, Dean J.
    Yeh, Robert W.
    Massaro, Joseph M.
    Driscoll-Shempp, Priscilla
    Cutlip, Donald E.
    Steg, P. Gabriel
    Gershlick, Anthony H.
    Darius, Harald
    Meredith, Ian T.
    Ormiston, John
    Tanguay, Jean-Francois
    Windecker, Stephan
    Garratt, Kirk N.
    Kandzari, David E.
    Lee, David P.
    Simon, Daniel I.
    Iancu, Adrian Corneliu
    Trebacz, Jaroslaw
    Mauri, Laura
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12) : 1552 - 1562
  • [23] Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy
    Lee, Michael S.
    Kobashigawa, Jon
    Tobis, Jonathan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (06) : 710 - 715
  • [24] Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
    Ahmed, Talha
    Pacha, Homam Moussa
    Addoumieh, Antoine
    Koutroumpakis, Efstratios
    Song, Juhee
    Charitakis, Konstantinos
    Boudoulas, Konstantinos Dean
    Cilingiroglu, Mehmet
    Marmagkiolis, Konstantinos
    Grines, Cindy
    Iliescu, Cezar A.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [25] Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
    Valgimigli, Marco
    Patialiakas, Athanasios
    Thury, Attila
    McFadden, Eugene
    Colangelo, Salvatore
    Campo, Gianluca
    Tebaldi, Matteo
    Ungi, Imre
    Tondi, Stefano
    Roffi, Marco
    Menozzi, Alberto
    de Cesare, Nicoletta
    Garbo, Roberto
    Meliga, Emanuele
    Testa, Luca
    Gabriel, Henrique Mesquita
    Airoldi, Flavio
    Ferlini, Marco
    Liistro, Francesco
    Dellavalle, Antonio
    Vranckx, Pascal
    Briguori, Carlo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (08) : 805 - 815
  • [26] Drug-eluting stents are as safe as bare-metal stents in patients with diabetes
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (10): : 594 - 595
  • [27] Outcomes in the Era of Bare-Metal Stents vs the Era of Drug-Eluting Stents
    Beri, Abhimanyu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (01): : 33 - 33
  • [28] Use of Antiplatelet Therapy after Percutaneous Coronary Intervention with Bare-Metal Stents and Different Types of Drug-Eluting Stents
    Singh, Tarunjit
    Cuomo, Linda
    Cohen, Martin
    Ahmad, Hasan A.
    Aronow, Wilbert S.
    CURRENT CLINICAL PHARMACOLOGY, 2013, 8 (01): : 59 - 66
  • [29] Drug-eluting stents versus bare-metal stents for acute coronary syndrome
    Feinberg, Joshua
    Nielsen, Emil Eik
    Greenhalgh, Janette
    Hounsome, Juliet
    Sethi, Naqash J.
    Safi, Sanam
    Gluud, Christian
    Jakobsen, Janus C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (08):
  • [30] Critical role of bare-metal stent controls in trials of drug-eluting stents:: reply
    Kastrati, A
    Pache, J
    Dibra, A
    Schömig, A
    EUROPEAN HEART JOURNAL, 2005, 26 (16) : 1687 - 1687
12345